GNPTAB and mucolipidosis: To further understand the relationship between GNPTAB dysfunction and EBOV infection, we tested fibroblasts from six patients with MLIII, a less severe form of mucolipidosis, usually characterized by a residual level of GlcNAc-phosphotransferase activity.